Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385972113> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W4385972113 abstract "Abstract Background. Episil ® is a non-absorbable liquid medical material used to cover and protect oral lesions, particularly those caused by mucositis associated with chemotherapy and radiation therapy. While there are some scattered reports on its use in head and neck cancer, there have been few studies in other malignancies. Methods. In this study, 38 patients with hematologic malignancies treated for oral mucositis (OM) with Episil ® at the Hiroshima Red Cross & Atomic-bomb Survivors Hospital were included; the degree of OM before and after use was examined. Of these 23 patients were interviewed about the effects of OM on pain, conversation, and eating, using our original evaluation protocol, and the results were compared. Results. The severity of mucositis decreased after the use of Episil ® in eight patients (21%), particularly in those with mucositis at multiple sites. Patient evaluations showed significant pain relief and improvements in speech and feeding functions. Patients with Grade 3 mucositis had higher ratings for improvement in pain relief, speech, and eating functions than those with Grade 2. Conclusions. Episil ® performed well in patients with hematologic malignancies and was particularly effective in multiple mucositis. In addition to pain relief, Episil has been suggested to improve speech and feeding functions effectively." @default.
- W4385972113 created "2023-08-19" @default.
- W4385972113 creator A5023393005 @default.
- W4385972113 creator A5039251561 @default.
- W4385972113 creator A5046771313 @default.
- W4385972113 creator A5051701229 @default.
- W4385972113 creator A5078986607 @default.
- W4385972113 creator A5080662081 @default.
- W4385972113 creator A5081114260 @default.
- W4385972113 creator A5090251942 @default.
- W4385972113 date "2023-08-19" @default.
- W4385972113 modified "2023-10-06" @default.
- W4385972113 title "Comparative study before and after the use of Episil ® oral liquid in patients with hematological malignancies" @default.
- W4385972113 cites W1978454448 @default.
- W4385972113 cites W1997007370 @default.
- W4385972113 cites W2034042543 @default.
- W4385972113 cites W2092502463 @default.
- W4385972113 cites W2117001635 @default.
- W4385972113 cites W2125101967 @default.
- W4385972113 cites W2144367231 @default.
- W4385972113 cites W2146402750 @default.
- W4385972113 cites W2160115655 @default.
- W4385972113 cites W2902634098 @default.
- W4385972113 cites W2910781800 @default.
- W4385972113 cites W2914772983 @default.
- W4385972113 cites W3004109749 @default.
- W4385972113 cites W3092643048 @default.
- W4385972113 cites W3129779784 @default.
- W4385972113 cites W3209233528 @default.
- W4385972113 cites W4211061884 @default.
- W4385972113 cites W4220972649 @default.
- W4385972113 cites W4224988143 @default.
- W4385972113 cites W4225009815 @default.
- W4385972113 cites W4241153091 @default.
- W4385972113 cites W4281637725 @default.
- W4385972113 cites W4285596309 @default.
- W4385972113 cites W4311662079 @default.
- W4385972113 cites W4315646642 @default.
- W4385972113 doi "https://doi.org/10.21203/rs.3.rs-3180512/v1" @default.
- W4385972113 hasPublicationYear "2023" @default.
- W4385972113 type Work @default.
- W4385972113 citedByCount "0" @default.
- W4385972113 crossrefType "posted-content" @default.
- W4385972113 hasAuthorship W4385972113A5023393005 @default.
- W4385972113 hasAuthorship W4385972113A5039251561 @default.
- W4385972113 hasAuthorship W4385972113A5046771313 @default.
- W4385972113 hasAuthorship W4385972113A5051701229 @default.
- W4385972113 hasAuthorship W4385972113A5078986607 @default.
- W4385972113 hasAuthorship W4385972113A5080662081 @default.
- W4385972113 hasAuthorship W4385972113A5081114260 @default.
- W4385972113 hasAuthorship W4385972113A5090251942 @default.
- W4385972113 hasBestOaLocation W43859721131 @default.
- W4385972113 hasConcept C121608353 @default.
- W4385972113 hasConcept C126322002 @default.
- W4385972113 hasConcept C2776530083 @default.
- W4385972113 hasConcept C2776694085 @default.
- W4385972113 hasConcept C2778496288 @default.
- W4385972113 hasConcept C509974204 @default.
- W4385972113 hasConcept C71924100 @default.
- W4385972113 hasConceptScore W4385972113C121608353 @default.
- W4385972113 hasConceptScore W4385972113C126322002 @default.
- W4385972113 hasConceptScore W4385972113C2776530083 @default.
- W4385972113 hasConceptScore W4385972113C2776694085 @default.
- W4385972113 hasConceptScore W4385972113C2778496288 @default.
- W4385972113 hasConceptScore W4385972113C509974204 @default.
- W4385972113 hasConceptScore W4385972113C71924100 @default.
- W4385972113 hasLocation W43859721131 @default.
- W4385972113 hasOpenAccess W4385972113 @default.
- W4385972113 hasPrimaryLocation W43859721131 @default.
- W4385972113 hasRelatedWork W1572341506 @default.
- W4385972113 hasRelatedWork W2035047172 @default.
- W4385972113 hasRelatedWork W2084326060 @default.
- W4385972113 hasRelatedWork W2380931084 @default.
- W4385972113 hasRelatedWork W2382840329 @default.
- W4385972113 hasRelatedWork W2997164716 @default.
- W4385972113 hasRelatedWork W2997863652 @default.
- W4385972113 hasRelatedWork W3018959328 @default.
- W4385972113 hasRelatedWork W3025392928 @default.
- W4385972113 hasRelatedWork W3028617786 @default.
- W4385972113 isParatext "false" @default.
- W4385972113 isRetracted "false" @default.
- W4385972113 workType "article" @default.